Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
AbbVie Inc. (ABBV)
Sector: Healthcare; Industry: Drug Manufacturers—General

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-24 SALEKI-GERHARDT AZITA EVP, Operations Sell 86,920 $116.29 $10,108,033 Yes
2021-05-03 Strom Carrie C SVP & Pres Global Allerg Aesth Sell 4,184 $112.40 $470,282 Yes
2021-03-01 RICHMOND TIMOTHY J. EVP, Chief HR Officer Sell 19,514 $108.59 $2,119,041 No
2021-03-01 Sorg Elaine K. SVP, US Commercial Operations Sell 8,440 $108.61 $916,642 No
2021-03-02 GONZALEZ RICHARD A Chairman of the Board and CEO Sell 170,113 $108.61 $18,476,204 Yes
2021-03-01 Stewart Jeffrey Ryan SVP, US Commercial Operations Sell 13,773 $108.59 $1,495,576 No
2021-02-22 Sorg Elaine K. SVP, US Commercial Operations Sell 20,195 $104.72 $2,114,732 Yes
2020-12-29 Stewart Jeffrey Ryan EVP, Commercial Operations Sell 25,290 $105.00 $2,655,450 Yes
2020-11-27 RICHMOND TIMOTHY J. EVP, Chief HR Officer Sell 51,990 $105.00 $5,458,950 Yes
2020-11-20 Gosebruch Henry O EVP, Chief Strategy Officer Sell 40,000 $99.38 $3,975,046 No
2020-11-16 ALBAN CARLOS Vice Chairman Sell 115,830 $100.00 $11,583,000 Yes
2020-11-10 SALEKI-GERHARDT AZITA EVP, Operations Sell 17,426 $98.00 $1,707,748 No
2020-11-04 SALEKI-GERHARDT AZITA EVP, Operations Sell 4,800 $93.61 $449,328 Yes
2020-11-12 GONZALEZ RICHARD A Chairman of the Board and CEO Sell 231,604 $96.88 $22,437,253 Yes
2020-11-04 SEVERINO MICHAEL Vice Chairman Sell 90,679 $93.61 $8,488,461 No
2020-11-04 SALEKI-GERHARDT AZITA EVP, Operations Sell 4,800 $93.61 $449,328 No
2020-07-07 ALBAN CARLOS Vice Chairman Sell 53,325 $100.00 $5,332,555 No
2020-05-12 Stewart Jeffrey Ryan SVP, US Commercial Operations Sell 23,024 $90.00 $2,072,211 No
2020-05-05 RICHMOND TIMOTHY J. EVP, Chief HR Officer Sell 19,445 $85.00 $1,652,825 No
2020-03-20 Durkin Brian L VP, Controller Buy 1,550 $69.00 $106,950 No
2020-03-20 Durkin Brian L VP, Controller Buy 3,750 $68.20 $255,755 No
2020-03-30 Durkin Brian L VP, Controller Buy 3,750 $68.20 $255,755 No
2020-03-03 RAPP EDWARD J Director Buy 2,875 $87.87 $252,617 No
2019-09-27 RICHMOND TIMOTHY J. EVP, Chief HR Officer Sell 15,515 $75.02 $1,163,873 No
2019-09-16 Schumacher Laura J Vice Chairman Buy 25,000 $70.42 $1,760,522 No
2019-08-29 Donoghoe Nicholas SVP, Enterprise Innovation Buy 7,525 $66.19 $498,057 No
2019-08-16 Stewart Jeffrey Ryan SVP, US Commercial Operations Buy 15,552 $64.44 $1,002,169 No
2019-08-01 AUSTIN ROXANNE S Director Buy 55,000 $65.86 $3,622,090 No
2019-07-30 AUSTIN ROXANNE S Director Buy 10,000 $66.35 $663,500 No
2019-07-29 Gosebruch Henry O EVP, Chief Strategy Officer Buy 30,000 $67.28 $2,018,385 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.